Results 151 to 160 of about 202,126 (199)

No-reflow phenomenon in the heart and brain [PDF]

open access: yesAmerican Journal of Physiology - Heart and Circulatory Physiology, 2018
The no-reflow phenomenon refers to the observation that when an organ is made ischemic by occlusion of a large artery supplying it, restoration of patency in that artery does not restore perfusion to the microvasculature supplying the parenchyma of that organ.
Kevin S KING, Michael G Harrington
exaly   +4 more sources

Coronary Microcirculation and the No-reflow Phenomenon

open access: yesCurrent Pharmaceutical Design, 2018
The no-reflow phenomenon refers to the post-percutaneous coronary intervention condition in which, despite re-establishing epicardial coronary vessel patency, the flow to the previously ischemic myocardium is markedly reduced. When it does occur, it attenuates the beneficial effect of reperfusion therapy and substantial regions of the myocardium fail
Evangelos Oikonomou   +2 more
exaly   +5 more sources

Coronary No-Reflow Phenomenon in Clinical Practice

open access: yesCurrent Pharmaceutical Design, 2018
Timely delivered coronary revascularization with no residual anatomical stenosis does not always lead to prompt restoration of anterograde coronary flow and complete myocardial reperfusion. This condition is known as coronary no-reflow and is associated with major clinical adverse events and poor prognosis. The pathophysiology of no-reflow phenomenon
Marialuisa Scarpone   +2 more
exaly   +5 more sources

No-reflow phenomenon in stroke patients: A systematic literature review and meta-analysis of clinical data [PDF]

open access: yesInternational Journal of Stroke
BackgroundThe no-reflow phenomenon refers to the absence of microvascular reperfusion despite macrovascular reperfusion.AimThe aim of this analysis was to summarize the available clinical evidence on no-reflow in patients with acute ischemic stroke ...
Adnan Mujanović   +2 more
exaly   +3 more sources

The challenges of coronary no‐reflow phenomenon

Catheterization and Cardiovascular Interventions, 2021
Key Points Proof‐of‐concept study demonstrates that intracoronary epinephrine could provide substantial improvement in coronary flow in ST‐elevation myocardial infarction refractory coronary no‐reflow during primary percutaneous coronary intervention.
Brian C. Case, Lowell F. Satler
openaire   +2 more sources

Home - About - Disclaimer - Privacy